Metabolic Medications, Mental Health Outcomes: Understanding GLP-1s Glucagon-like peptide-1 receptor agonists (GLP-1s) are increasingly prescribed for the treatment of diabetes and obesity, with growing interest in their potential impact on mental health outcomes. As more clients present with histories of GLP-1 use, mental health professionals must understand both the physiological and psychological implications of these […]